Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$10.75 USD
+0.03 (0.28%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $10.75 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$10.75 USD
+0.03 (0.28%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $10.75 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth F Momentum B VGM
Zacks News
Service Corporation (SCI) Up on Solid Cemetery Unit, Expansions
by Zacks Equity Research
Service Corporation (SCI) is benefiting from robust revenues in its Cemetery segment. Also, the company's strategic investments are driving growth.
Zacks.com featured highlights include: Nu Skin Enterprises, Caleres Inc., Preferred Apartment Communities, Inc., Schneider National and MDU Resources Group
by Zacks Equity Research
Nu Skin Enterprises, Caleres Inc., Preferred Apartment Communities, Inc., Schneider National and MDU Resources Group are included in this blog.
The Estee Lauder Companies (EL) Gains 38% in a Year: Here's Why
by Zacks Equity Research
The Estee Lauder Companies' (EL) Skin Care portfolio has been performing well for a while now. The company's online operations also look impressive.
Tap These 5 Low Price-to-Sales Stocks to Get Standout Returns
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks incurring losses or are in an early development cycle. Stocks like NUS, CAL, APTS, SNDR and MDU hold promise.
Here's Why Hold Strategy is Apt for Newell (NWL) Stock Now
by Zacks Equity Research
Newell (NWL) is poised for growth on solid demand, product innovation, e-commerce growth, and robust core sales growth. Cost inflation and supply-chain issues remain headwinds.
Nu Skin Enterprises (NUS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Nu Skin Enterprises (NUS) closed at $50.75, marking a -0.65% move from the previous day.
Nu Skin's (NUS) Transformational Strategies Keep It Well-Placed
by Zacks Equity Research
Nu Skin (NUS) gains on its solid customer base and network of sales leaders. The company's three transformational strategies also bode well amid pandemic-led disruptions.
Nu Skin Enterprises (NUS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Nu Skin Enterprises (NUS) closed the most recent trading day at $49.50, moving -1.16% from the previous trading session.
Nu Skin Enterprises (NUS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Nu Skin Enterprises (NUS) closed at $50.08, marking a +1.36% move from the previous day.
General Mills (GIS) Queued Up for Q2 Earnings: Factors to Watch
by Zacks Equity Research
General Mills' (GIS) second-quarter fiscal 2022 performance will likely reflect robust at-home food demand. However, higher input cost inflation is a concern.
Nu Skin Enterprises (NUS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Nu Skin Enterprises (NUS) closed the most recent trading day at $47.13, moving -1.09% from the previous trading session.
Why Is Nu Skin (NUS) Up 3.7% Since Last Earnings Report?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for November 30th
by Zacks Equity Research
BJRI, DLB, NUS, TXRH, and GPS have been added to the Zacks Rank #5 (Strong Sell) List on November 30, 2021.
New Strong Sell Stocks for November 18th
by Zacks Equity Research
XRX, SHOP, IBM, BLMN, and NUS have been added to the Zacks Rank #5 (Strong Sell) List on November 18, 2021.
Nu Skin (NUS) Q3 Earnings Beat Estimates, Revenues Down
by Zacks Equity Research
Nu Skin's (NUS) third-quarter 2021 earnings and revenues decline year over year on disruptions caused by the Delta variant. Also, management lowered 2021 revenue guidance.
Nu Skin Enterprises (NUS) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 12.79% and 0.31%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Factors to Consider as Nu Skin (NUS) Gears Up for Q3 Earnings
by Zacks Equity Research
Nu Skin's (NUS) third-quarter results are likely to reflect the impact of delta variant across various markets, though focus on enhancing sales leaders has been a driver.
Nu Skin Enterprises (NUS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Nu Skin Enterprises (NUS) closed at $40.19 in the latest trading session, marking a +1.01% move from the prior day.
Earnings Preview: Nu Skin Enterprises (NUS) Q3 Earnings Expected to Decline
by Zacks Equity Research
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nu Skin Enterprises (NUS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Nu Skin Enterprises (NUS) closed the most recent trading day at $41.07, moving -0.85% from the previous trading session.
New Strong Sell Stocks for October 18th
by Zacks Equity Research
CNFR, RACE, GGG, NUS, and LRN have been added to the Zacks Rank #5 (Strong Sell) List on October 18, 2021.
The Estee Lauder Companies (EL) Gains on Online & Skin Care Sales
by Zacks Equity Research
Strength in The Estee Lauder Companies' (EL) Skin Care portfolio is a major driver. Also, the company is implementing stringent cost-curtailment practices.
Nu Skin's (NUS) Solid Innovations Aid, Pandemic-Led Hurdles Hurt
by Zacks Equity Research
Nu Skin (NUS) is benefiting from effective product launches. However, the company is battling challenges stemming from the spread of the delta variant across several markets.
Nu Skin (NUS) Lowers Q3 Revenue View Amid Pandemic-Led Hurdles
by Zacks Equity Research
Nu Skin (NUS) expects Q3 revenues in the band of $637-$642 million, lower than the previous range. Challenges caused by the delta variant across several markets are a downside.
Zacks.com featured highlights include: Academy Sports and Outdoors, M/I Homes, MetLife, ArcelorMittal and Nu Skin Enterprises
by Zacks Equity Research
Zacks.com featured highlights include: Academy Sports and Outdoors, M/I Homes, MetLife, ArcelorMittal and Nu Skin Enterprises